The company's purpose is to research, develop clinically, manufacture and produce pharmaceutical, biological and chemical products, in particular mRNA vaccines, in Switzerland and abroad, as well as all related operations. The company may carry out all commercial, financial or asset-related transactions and conclude all contracts that have a direct or indirect connection with its purpose and promote its development. The company may also acquire participations in other companies and acquire companies with an identical or similar purpose, establish branches or form subsidiaries in Switzerland or abroad, provided that the company may only hold participations in real estate companies in Switzerland if the use of their properties is exclusively commercial. The company may grant loans or any other form of financing to affiliated companies, as well as provide any type of security, for the direct or indirect benefit of affiliated companies (or third parties), in particular in the form of guarantees, pledges or fiduciary transfers of the company's assets.
Outbound Leads by COHAGA